{{Rsnum
|rsid=8083432
|Gene=ZNF521
|Chromosome=18
|position=25151396
|Orientation=plus
|GMAF=0.1997
|Gene_s=ZNF521
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 66.4 | 31.9 | 1.8
| HCB | 77.9 | 21.3 | 0.7
| JPT | 76.1 | 20.4 | 3.5
| YRI | 62.6 | 34.0 | 3.4
| ASW | 47.4 | 43.9 | 8.8
| CHB | 77.9 | 21.3 | 0.7
| CHD | 78.0 | 21.1 | 0.9
| GIH | 64.4 | 33.7 | 2.0
| LWK | 50.0 | 42.7 | 7.3
| MEX | 46.6 | 46.6 | 6.9
| MKK | 64.1 | 33.3 | 2.6
| TSI | 61.8 | 33.3 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22379998
|Trait=None
|Title=Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
|RiskAllele=
|Pval=0.000006
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}